Atlantic Therapeutics snags Series B funding

Atlantic Therapeutics, a medical technology company focused on treating bladder leaks, has secured 28 million euros in Series B funding. LSP led the round with participation from other investors that included Andera Partners, Atlantic Bridge Ventures, Seroba Life Sciences and Earlybird Venture Capital.

7 January 2019•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail